Roberto Sanchez

Roberto Sanchez has over 25 years of work experience. Roberto began their career in 1993 as a Research Fellow at ICGEB. In 1995, they became a Graduate Student at The Rockefeller University. In 2000, they joined the Icahn School of Medicine at Mount Sinai as a Director of Structure-Based Drug Discovery (Drug Discovery Institute) and Associate Professor of Pharmacological Sciences. Theirrole included developing, implementing, and supervising computational strategies for compound discovery and optimization in academic drug discovery projects in cancer, diabetes, metabolic and cardiovascular diseases, as well as in silico discovery of new inhibitors/antagonists for enzymes, GPCRs, nuclear receptors, and kinases, and new agonists/activators for GPCRs, nuclear receptors and SUMO ligase. In 2021, they were appointed as the Director of Computational Chemistry at ROME Therapeutics.

Roberto Sanchez completed their Bachelor of Science in Biochemistry from Universidad de Concepción in 1993. Roberto then went on to earn their Doctor of Philosophy (Ph.D.) from The Rockefeller University in 2000.